EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Decoding the Dynamics of Circulating Tumor DNA in Liquid Biopsies

Khadija Turabi, Kelsey Klute, Prakash Radhakrishnan iD

Cancers · 01.07.2024 · 16 (13) · 2432

DOI: 10.3390/cancers16132432 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Cancers, online erschienen am 01.07.2024. Verfasst von Khadija Turabi und 2 weiteren Autor:innen. Beteiligte Einrichtung: Eppley Institute for Research in Cancer and Allied Diseases, University of Nebraska Medical Center, Omaha, NE 68198, USA. Die Arbeit wurde bisher 39-mal zitiert (Crossref) und nennt 166 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NCI NIH HHS, American Cancer Society, Buffett Cancer Center.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Circulating tumor DNA (ctDNA), a fragment of tumor DNA found in the bloodstream, has emerged as a revolutionary tool in cancer management. This review delves into the biology of ctDNA, examining release mechanisms, including necrosis, apoptosis, and active secretion, all of which offer information about the state and nature of the tumor. Comprehensive DNA profiling has been enabled by methods such as whole genome sequencing and methylation analysis. The low abundance of the ctDNA fraction makes alternative techniques, such as digital PCR and targeted next-generation exome sequencing, more valuable and accurate for mutation profiling and detection. There are numerous clinical applications for ctDNA analysis, including non-invasive liquid biopsies for minimal residual disease monitoring to detect cancer recurrence, personalized medicine by mutation profiling for targeted therapy identification, early cancer detection, and real-time evaluation of therapeutic response. Integrating ctDNA analysis into routine clinical practice creates promising avenues for successful and personalized cancer care, from diagnosis to treatment and follow-up.

Schlagwörter

Stichwörter der Autor:innen

NGScirculating tumor DNAdigital droplet PCRearly detectionminimal residual disease

Autor:innen und Institutionen

  • Eppley Institute for Research in Cancer and Allied Diseases, University of Nebraska Medical Center, Omaha, NE 68198, USA.
  • Fred & Pamela Buffett Cancer Center, University of Nebraska Medical Center, Omaha, NE 68198, USA.
  • Division of Oncology and Hematology, Department of Internal Medicine, University of Nebraska Medical Center, Omaha, NE 68198, USA.

ORCID-Profile: Prakash Radhakrishnan

Förderung

  • NCI NIH HHS
  • American Cancer Society
  • Buffett Cancer Center

Zitieren

APA

Turabi, K., Klute, K., & Radhakrishnan, P. (2024). Decoding the Dynamics of Circulating Tumor DNA in Liquid Biopsies. Cancers, 16(13), 2432. https://doi.org/10.3390/cancers16132432

Vancouver

Turabi K, Klute K, Radhakrishnan P. Decoding the Dynamics of Circulating Tumor DNA in Liquid Biopsies. Cancers. 2024;16(13):2432. doi:10.3390/cancers16132432

BibTeX
@article{Turabi2024,
  author = {Turabi, Khadija and Klute, Kelsey and Radhakrishnan, Prakash},
  title = {Decoding the Dynamics of Circulating Tumor DNA in Liquid Biopsies},
  journal = {Cancers},
  year = {2024},
  volume = {16},
  number = {13},
  pages = {2432},
  doi = {10.3390/cancers16132432}
}
Kostenlos starten →